Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken B Johnson

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Anesthesia and Analgesia|July 25, 2012
New horizons in sedative hypnotic drug development: fast, clean, and softKen B Johnson
Current Opinion in Anaesthesiology|May 26, 2018
New horizons in anesthetic clinical pharmacology, patient outcomes and perioperative neuromonitoringKen B Johnson
Anesthesia and Analgesia|August 16, 2024
Driving Residual Neuromuscular Blockade to Zero: Precision MattersKen B Johnson
Current Opinion in Anaesthesiology|June 14, 2023
Clarifying the grey space of sugammadex induced bradycardiaKen B Johnson, Rebeca Chacin
Anesthesia and Analgesia|September 27, 2016
The Three Laws of Autonomous and Closed-Loop Systems in AnesthesiaKai Kuck, Ken B Johnson
Anesthesiology|November 8, 2016
Innovative Disruption in the World of Neuromuscular Blockade: What Is the "State of the Art?"Mohamed Naguib, Ken B Johnson
Regional Anesthesia and Pain Medicine|June 4, 2020
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative painJason Hafer, Ken B Johnson
Anesthesia and Analgesia|October 21, 2022
Utilizing Pharmacogenomic Data in Perioperative Medicine: Feasibility, Value, and InevitabilityStuart A Forman, Ken B Johnson
Anesthesia and Analgesia|January 2, 2025
Neostigmine: Incompletely Understood and Perhaps Incorrectly UtilizedStephan R Thilen, Ken B Johnson
Anesthesia and Analgesia|December 14, 2020
Chasing Shadows, Catching Smoke, and Estimating Anaphylaxis to SugammadexKen B Johnson, Richard P Dutton
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Anesthesia and Analgesia|July 25, 2012
New horizons in sedative hypnotic drug development: fast, clean, and softKen B Johnson
Current Opinion in Anaesthesiology|May 26, 2018
New horizons in anesthetic clinical pharmacology, patient outcomes and perioperative neuromonitoringKen B Johnson
Anesthesia and Analgesia|August 16, 2024
Driving Residual Neuromuscular Blockade to Zero: Precision MattersKen B Johnson
Current Opinion in Anaesthesiology|June 14, 2023
Clarifying the grey space of sugammadex induced bradycardiaKen B Johnson, Rebeca Chacin
Anesthesia and Analgesia|September 27, 2016
The Three Laws of Autonomous and Closed-Loop Systems in AnesthesiaKai Kuck, Ken B Johnson
Anesthesiology|November 8, 2016
Innovative Disruption in the World of Neuromuscular Blockade: What Is the "State of the Art?"Mohamed Naguib, Ken B Johnson
Regional Anesthesia and Pain Medicine|June 4, 2020
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative painJason Hafer, Ken B Johnson
Anesthesia and Analgesia|October 21, 2022
Utilizing Pharmacogenomic Data in Perioperative Medicine: Feasibility, Value, and InevitabilityStuart A Forman, Ken B Johnson
Anesthesia and Analgesia|January 2, 2025
Neostigmine: Incompletely Understood and Perhaps Incorrectly UtilizedStephan R Thilen, Ken B Johnson
Anesthesia and Analgesia|December 14, 2020
Chasing Shadows, Catching Smoke, and Estimating Anaphylaxis to SugammadexKen B Johnson, Richard P Dutton
Pageof 7